Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H OERTEL

Showing results (131-140 of 678) with videos related to

Pageof 68
Sort By:
Clinical Neuropharmacology|May 27, 2010
Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group studyVincent Ries, Roland Selzer, Tobias Eichhorn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2019
The locus coeruleus: Another vulnerability target in Parkinson's diseaseWolfgang H Oertel, Martin T Henrich, Annette Janzen, et al.
Brain Research. Molecular Brain Research|June 3, 1999
Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's diseaseC Sommer, M Sabel, W H Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2002
Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI studyGuy Arnold, Klaus Tatsch, Eduardo Kraft, et al.
Seizure|July 24, 2001
Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS)J C Möller, H M Hamer, W H Oertel, et al.
CNS & Neurological Disorders Drug Targets|November 30, 2007
Adult neurogenesis and Parkinson's diseaseOscar Arias-Carrión, Nils Freundlieb, Wolfgang H Oertel, et al.
The Journal of Comparative Neurology|January 16, 2014
Origin of the dopaminergic innervation of adult neurogenic areasGünter U Höglinger, Oscar Arias-Carrión, Bastian Ipach, et al.
Sleep Medicine|May 19, 2018
Validation of semiautomatic scoring of REM sleep without atonia in patients with RBDD Guttowski, G Mayer, W H Oertel, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 24, 2001
New approaches to dissect degeneracy and specificity in T cell antigen recognitionM Jacobsen, S Cepok, W H Oertel, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trialJ Schwarz, C Trenkwalder, T Gasser, et al.
Pageof 68

Showing results (131-140 of 678) with videos related to

Sort By:
Pageof 68
Clinical Neuropharmacology|May 27, 2010
Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group studyVincent Ries, Roland Selzer, Tobias Eichhorn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2019
The locus coeruleus: Another vulnerability target in Parkinson's diseaseWolfgang H Oertel, Martin T Henrich, Annette Janzen, et al.
Brain Research. Molecular Brain Research|June 3, 1999
Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's diseaseC Sommer, M Sabel, W H Oertel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2002
Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI studyGuy Arnold, Klaus Tatsch, Eduardo Kraft, et al.
Seizure|July 24, 2001
Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS)J C Möller, H M Hamer, W H Oertel, et al.
CNS & Neurological Disorders Drug Targets|November 30, 2007
Adult neurogenesis and Parkinson's diseaseOscar Arias-Carrión, Nils Freundlieb, Wolfgang H Oertel, et al.
The Journal of Comparative Neurology|January 16, 2014
Origin of the dopaminergic innervation of adult neurogenic areasGünter U Höglinger, Oscar Arias-Carrión, Bastian Ipach, et al.
Sleep Medicine|May 19, 2018
Validation of semiautomatic scoring of REM sleep without atonia in patients with RBDD Guttowski, G Mayer, W H Oertel, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 24, 2001
New approaches to dissect degeneracy and specificity in T cell antigen recognitionM Jacobsen, S Cepok, W H Oertel, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trialJ Schwarz, C Trenkwalder, T Gasser, et al.
Pageof 68